Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV-15) compared to PCV-13 in healthy older adults

Background: Pneumococcal disease remains a public health priority in adults. Safety and immunogenicity of 2 different formulations of 15-valent pneumococcal conjugate vaccine (PCV15) containing 13 serotypes included in 13-valent pneumococcal conjugate vaccine (PCV13) plus 2 additional serotypes (22F...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Hum Vaccin Immunother
Main Authors: Stacey, Helen L., Rosen, Jeffrey, Peterson, James T., Williams-Diaz, Angela, Gakhar, Vanita, Sterling, Tina M., Acosta, Camilo J., Nolan, Katrina M., Li, Jianing, Pedley, Alison, Benner, Patrice, Abeygunawardana, Chitrananda, Kosinski, Michael, Smith, William J., Pujar, Hari, Musey, Luwy K.
Format: Artigo
Jezik:Inglês
Izdano: Taylor & Francis 2019
Teme:
Research Paper
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6605726/
https://ncbi.nlm.nih.gov/pubmed/30648919
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2018.1532249
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki